Cholesterol Research Today is a free monthly online journal that collates and summarizes the latest research about Cholesterol, including details on high cholesterol, hdl, ldl, diet, risks.

Volume 3 (2006), Issue 4 (April)

1. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities.
   Clin Chim Acta, 367(1): 69-76. [Abstract] [Full-text]
2. Enhanced hepatic uptake and bioactivity of type alpha1(I) collagen gene promoter-specific triplex-forming oligonucleotides after conjugation with cholesterol.
   J Pharmacol Exp Ther, 317(2): 797-805. [Abstract] [Full-text]
3. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia.
   Arterioscler Thromb Vasc Biol, 26(5): 1107-13. [Abstract] [Full-text]
4. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages.
   Arterioscler Thromb Vasc Biol, 26(5): 1169-76. [Abstract] [Full-text]
5. Cellular cholesterol controls TRPC3 function: evidence from a novel dominant-negative knockdown strategy.
   Biochem J, 396(1): 147-55. [Abstract] [Full-text]
6. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
   Metabolism, 55(5): 662-8. [Abstract] [Full-text]
7. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
   Metabolism, 55(5): 599-604. [Abstract] [Full-text]
8. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
   J Intern Med, 259(5): 455-61. [Abstract] [Full-text]
9. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
   Invest Ophthalmol Vis Sci, 47(5): 2172-8. [Abstract] [Full-text]
10. Serum lipids and low back pain: an association? A follow-up study of a working population sample.
    Spine, 31(9): 1032-7. [Abstract] [Full-text]
11. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.
    Am Heart J, 151(5): 975.e1-9. [Abstract] [Full-text]

© 2004-2008 Cholesterol Research Today. All Rights Reserved.